first dose of retatrutide VisualAbstract: reduces body weight by 17.5% in patients with obesity Retatrutide Starting Dose: Full Dosing

Retatrutide has become a major focus in modern metabolic and obesity research

The most serious side-effects, but which are rare, limit their use in persons having a history of pancreatis (inflammation of the pancreas) or thyroid cancer antecedents (due to the presence of GLP-1 receptors in the thyroid)

2022;185:2478-94.e28

As we learn more about the antiinflammatory properties of incretin-based therapies, it becomes likely that they could be effective across a wide spectrum of diseases

While ColonBroom GLP-1 Booster is made from non-GMO, vegan-friendly ingredients in cGMP-certified facilities and is stimulant-free, it's important to note that results may vary

Ozempic is generally well-tolerated, with the most common side effects being gastrointestinal, including nausea, diarrhoea, and vomiting